Aura Biosciences, Inc. — Director's Dealing 2021

Oct 28, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aura Biosciences, Inc. (AURA)
CIK: 0001501796
Period of Report: 2021-10-28

Reporting Person: De Rosch Mark (Chief Operating Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$5.48	2031-03-23	Common Stock (56620)		Direct
Stock Option (Right to Buy)	$5.48	2031-06-28	Common Stock (125547)		Direct

Footnotes

F1: 25% of the original number of Shares on the first anniversary of March 15, 2021 with the remainder vesting in 36 substantially equal monthly installments.

F2: The shares underlying this option vest in 48 monthly installments, equal to 2.0833% of the shares, over the 48 months following June 28, 2021.